Triple-Negative Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — Triple-Negative Breast Cancer (Session 2)

published 1 month ago by Dr Neil Love

Featuring perspectives from Dr Joyce O'Shaughnessy on following topics: Introduction (0:00) Case Presentations from Alan B Astrow, MD on Chemotherapy for Triple-Negative Breast Cancer (TNBC) A woman in her late 80s with triple-negative lobular carcinoma (1:54) A woman in her mid-60s with triple-negative, node-positive breast cancer (6:30) A woman in her early 30s with triple-negative, node-negative infiltrating ductal carcinoma (IDC) (14:39) San Antonio Breast Cancer Symposium (SABCS®) Review — Immunotherapy for Advanced TNBC (20:25) Case Presentations from Dr Astrow and SABCS Review of Data on Immunotherapy Combinations and PARP Inhibition for TNBC A woman in her early 40s with metastatic TNBC (31:08) A woman in her early 60s with a germline BRCA1 mutation and locally advanced breast cancer (36:14) Case Presentations from Dr Astrow on Triple-Negative Small Cell Carcinoma of the Breast and Triple-Negative IDC; Sacituzumab Govitecan for Patients with TNBC A woman in her mid-40s with triple-negative small cell carcinoma of the breast (48:11) A woman in her late 30s with triple-negative IDC (51:44) CME information and select publications

more episodes from Research To Practice | Oncology Videos